Definitive Contract HHSO100201600007C
Award Date
5/16/16
Potential Completion Date
8/31/23
Potential Value
$20M
Awardee
Sri International
Ultimate Awardee
Not listed
NAICS Category
541711 - Research and Development in Biotechnology
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
West Menlo Park, CA 94025, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
<p>This is a $41,423,587.45 cost-plus-fixed-fee contract awarded by the U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, to First Light Diagnostics, Inc. The contract is for the development of a "RAPID, SENSITIVE, AND COST-EFFECTIVE ANTHRAX TEST AND CLINICAL SURGE-TESTING PLATFORM" and has an ultimate completion date of November 30, 2023. The contract is a definitive contract and does not have a set-aside designation.</p>
This is a $6,607,920.00 cost-plus-fixed-fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to SRI International, a non-profit research and development institute. The contract is for the development of a novel plasma protein biomarker panel for a radiation/nuclear triage biodosimetry device, referred to as the "RAPID RAD DX" project. This contract award is not...
This is a $7,751,590.00 cost-plus-fixed-fee delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to SRI International, a non-profit research and development institute. The contract is for the development and testing of animal models for monoclonal countermeasures (MCMs). There is no set-aside designation. The contract includes a subcontract with the University of Maryland, Baltimore to identify and validate radiation-induced biomarkers...
This is a $17,487,089.00 definitive contract awarded by the Department of the Army Materiel Command Research Development and Engineering Command to the non-profit research institute SRI International. The contract is cost-plus-fixed-fee and does not have a set-aside designation. SRI International is a well-established provider of research, development, and advisory services to government agencies and commercial entities, with a focus on areas like biomedical sciences, computing, national...
This is a federal contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Pattern Bioscience, Inc., a biotechnology company, to develop a rapid pathogen identification and antimicrobial susceptibility testing platform. The contract, valued at $40,937,536.73, is for the verification, clinical evaluation, and U.S. Food and Drug Administration (FDA) clearance of this culture-free, phenotypic diagnostic platform. The contract is a...
This is a $4,950,919.00 federal contract award to SRI International, a non-profit research and development institute, to provide nonclinical services for the development of interventional agents for infectious diseases. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. SRI International has a robust history of providing advanced scientific and technical services to the federal...
This is a cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services (HHS), to SRI International, a non-profit research and development institute. The contract, valued at $715,633.86, is for radiation/nuclear medical countermeasure (MCM) product development support services, specifically the formulation of 3,4,3-Li(1,2-HOPO). This contract is not a set-aside and is part of a...
This is a $117,119.24 cost-plus-fixed-fee delivery order contract awarded to Sri International, a non-profit research and development institute, by the National Institute of Allergy and Infectious Diseases (NIAID). The contract is for the process development and synthesis of 100 grams of ARN0075039, a non-GMP material. It is part of the "Nonclinical Services for Development of Interventional Agents" indefinite delivery, indefinite quantity (IDIQ) contract vehicle. The award has no...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to SRI International, a non-profit research and development institute. The $11,484,358.00 cost-plus-fixed-fee contract is for RADIOLOGICAL/NUCLEAR MEDICAL COUNTERMEASURE (MCM) PRODUCT DEVELOPMENT SUPPORT, ADMINISTRATIVE AND TECHNICAL SUPPORT, with a period of performance through June 30, 2027. The contract is not set-aside. SRI...
This is a Cost Plus Fixed Fee delivery order contract awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to SRI International, a non-profit research institute, for $122,706.00. The contract is for nonclinical services to support the development of interventional agents for infectious diseases. It is not associated with a larger contract vehicle and does not have a set-aside designation. SRI International has a history of providing a range...